A Precision Medicine Approach to Elucidate Mechanisms of Progression

$318,833P50FY2015CANIH

University Of Michigan At Ann Arbor, Ann Arbor MI

Investigators

Linked publications, trials & patents

Paper 39763898 Paper 39531508 Paper 39503807 Paper 39388374 Paper 39352383 Paper 39321214 Paper 39251788 Paper 39227508 Paper 39040140 Paper 39029462 Paper 39020220 Paper 38990734 Paper 38942798 Paper 38787530 Paper 38773085 Paper 38699169 Paper 38635241 Paper 38586029 Paper 38562774 Paper 38557192 Paper 38551513 Paper 38464258 Paper 38464251 Paper 38464081 Paper 38461151 Paper 38328238 Paper 38328153 Paper 38011559 Paper 37698493 Paper 37471612 Paper 37440313 Paper 37382562 Paper 37289025 Paper 36909546 Paper 36828361 Paper 36585434 Paper 36526938 Paper 36382533 Paper 36264673 Paper 36251389 Paper 36109521 Paper 35963777 Paper 35938508 Paper 35930793 Paper 35909568 Paper 35878714 Paper 35737923 Paper 35513774 Paper 35385733 Paper 35195258 Paper 35082166 Paper 35008431 Paper 34973338 Paper 34937944 Paper 34906585 Paper 34764492 Paper 34753659 Paper 34738088 Paper 34503355 Paper 34473519 Paper 34312180 Paper 34226663 Paper 34206543 Paper 34145028 Paper 34001952 Paper 33972443 Paper 33958760 Paper 33916826 Paper 33840559 Paper 33792558 Paper 33785255 Paper 33727260 Paper 33662287 Paper 33630025 Paper 33513345 Paper 33496795 Paper 33442662 Paper 33310900 Paper 33283137 Paper 33119036 Paper 33080150 Paper 33046413 Paper 32997578 Paper 32967941 Paper 32857953 Paper 32694156 Paper 32671317 Paper 32661416 Paper 32659784 Paper 32631746 Paper 32462107 Paper 32424106 Paper 32403054 Paper 32396488 Paper 32299729 Paper 32231245 Paper 32217460 Trial NCT07645391 Trial NCT07526545 Trial NCT03300505

Abstract

The University of Michigan Comprehensive Cancer Center (UMCCC) has taken on a leadership role in developing precision medicine approaches for oncology. In April of 2011, the MI-ONCOSEQ clinical sequencing program was established, which prospectively enrolls patients with advanced cancers for comprehensive mutational analysis using an integrattve sequencing approach. Since establishment of this protocol, over 250 adults and 40 children with cancer have been sequenced with return of results through an Institutionally sanctioned

View original record on NIH RePORTER →